Published in Medical Letter on the CDC and FDA, February 20th, 2005
Menactra vaccine is the first quadrivalent conjugate vaccine licensed in the U.S. for the prevention of meningococcal disease and is designed to offer protection against 4 serogroups of Neisseria meningitidis (A, C, Y, W-135), the bacterium that causes meningococcal infection.
A supplemental licensure application in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.